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INTRODUCTION:  Pythiosis  is  a serious  life-  and  limb-threatening  infection  endemic  to  Thailand,  but  rarely
seen  in the  Western  hemisphere.  Here,  we present  a unique  case  of  vascular  pythiosis  initially  managed
with limb-sparing  vascular  bypass  grafts  complicated  by a pseudoaneurysm  in our repair.
PRESENTATION  OF CASE:  The  patient  is a  17  year-old  Jamaican  male  with  severe  aplastic  anemia.  He  sus-
tained a  minor  injury  to  his  left leg  while  ﬁshing  in  Jamaica,  which  evolved  to become  an  exquisitely  tender
inguinal  swelling.  His  physical  exam  and imaging  were  signiﬁcant  for arteriovenous  ﬁstula  with  limb
ischemia.  Pathology  obtained  during  surgery  for an extra-anatomic  vascular  bypass  showed  extensive
invasion  by  Pythium  insidiosum.  He  later  developed  a pseudoaneurysm  at the site of proximal  anastomosis
and  required  urgent  intervention.
DISCUSSION:  This patient  presented  with  a rare,  but classic  case  of  vascular  pythiosis,  which  was  unrec-
ognized  at  the time  of  presentation.  A  variety  of  therapeutic  modalities  have  been  used  to  treat  this
disease,  including  antibiotics,  antifungals,  and  immunotherapy,  but the ultimate  management  of  vascular
pythiosis  is surgical  source  control.
CONCLUSION:  A high  index of  suspicion  in  susceptible  patients  is  needed  for timely  diagnosis  of vascular
pythiosis  to achieve  optimal  source  control.
td.  on
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. Introduction
First described by veterinarians,1 pythiosis is a serious life- and
imb-threatening infection endemic to Thailand, but rarely seen
n the Western hemisphere.2 Known to infect immunocompetent
orses, dogs, and other large animals,2,3 Pythium infection was
rst reported in humans in 1989 in association with thalassemic
emoglobinopathy.4,5 Human pythiosis is known to present in
ne of four clinical entities: subcutaneous, ocular, vascular, and
isseminated.6 Here, we  present a unique case of vascular pythiosis
anaged with limb-sparing vascular bypass grafts complicated by
seudoaneurysm formation.. Presentation of case
The patient is a 17 year-old Jamaican male with a history of
aroxysmal nocturnal hemoglobinuria and severe aplastic anemia
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-3940, Bethesda, MD 20892, USA. Tel.: +1 301 496 4164.
E-mail addresses: pandalaipk@mail.nih.gov, pkpandalai@gmail.com
P.K. Pandalai).
ttp://dx.doi.org/10.1016/j.ijscr.2014.05.018
210-2612/Published by Elsevier Ltd. on behalf of Surgical Associates Ltd
http://creativecommons.org/licenses/by-nc-sa/3.0/). behalf  of Surgical  Associates  Ltd.  This  is an  open  access  article  under  the
C BY-NC-SA  license  (http://creativecommons.org/licenses/by-nc-sa/3.0/).
refractory to horse anti-thymoglobulin treatment, which was
transfusion-dependent. One month prior to admission at our insti-
tution, he went ﬁshing in a fresh water pond in Jamaica and his left
lower leg was  caught in a bush. On the following day, he noticed
a small bullae with a black center and later developed severely
painful left inguinal swelling. He was  admitted to a local hospital
for the next several weeks, where all diagnostic testing performed
was unremarkable. His pain persisted despite antibiotic and anti-
fungal therapy, and he was later transferred to our institution for
consideration of bone marrow transplant.
On admission, he was  a febrile with a white blood cell count
of 6.2 (K/L) and platelet count of 18 (K/L) and was complaining
of severe left leg pain. He had a 9 × 8 cm2 soft tissue defect with
overlying escar on the posterior aspect of his left leg (Fig. 1A), and
his exam was also notable for an exquisitely tender and erythe-
matous left inguinal mass. Motor and sensory exam were intact in
both lower extremities without pain upon passive hip ﬂexion. Sev-
eral small, dark macules were noted along the lateral aspect of his
left foot (Fig. 1B) and his left dorsalis pedis pulse was weaker than
the right. Most signiﬁcantly, he exhibited pain out of proportion to
exam ﬁndings.
MRI  showed a T2 bright left groin mass with edema along
the fascial planes, and lower extremity angiogram demonstrated
. This is an open access article under the CC BY-NC-SA license
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Fig. 1. (A) Ischemic ulcer with overly
Fig. 2. (A) Left common femoral artery occlusion with distal profunda femoris
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reconstitution with (B) small and underperfused superﬁcial femoral artery with
id-vessel reconstitution.
cclusion of the left common femoral artery with distal profunda
emoris and mid-superﬁcial femoral artery reconstitution (Fig. 2).
ue to the length of the diseased vessel, the patient was not a candi-
ate for percutaneous intervention, and was taken to the operating
oom for exploration. Visual inspection of the common femoral
rtery after exposure was signiﬁcant for several patches of necrotic
essel wall. Initial attempt with thrombectomy was unsuccessful,
s the Fogarty catheter actually perforated the anterior wall at the
reas of necrosis. The patient ultimately received an extra-anatomic
eft external iliac to superﬁcial femoral artery bypass using a non-
eversed greater saphenous vein graft, as the external iliac was the
Fig. 3. Left external iliac artery pseudoaneuing escar and (B) distal emboli.
closest available inﬂow that did not visually appear to be involved
with the infection.
Intraoperative wound cultures were positive for Pythium insid-
iosum and the patient was started on a combination of voriconazole,
terbinaﬁne, and amphotericin B. Given his critical condition, an
emergency Investigational New Drug request was drafted for per-
mission to administer a P. insidiosum antigen vaccine available for
compassionate use from the Pan American Veterinary Laboratories.
The vaccine was  given once daily in one-week intervals in conjunc-
tion with subcutaneously injected interferon gamma (IFN-), for
a total of four weeks. Iron chelation therapy was  also started as
adjunctive treatment.
Three weeks after his initial surgery, the patient developed new
sites of pain along the graft site and repeat imaging showed a 2.5 cm
pseudoaneurysm at the proximal anastomosis to the external iliac
artery with contrast extravasation (Fig. 3). He was taken to the
operating room for an extra-anatomic left common iliac artery to
the previous femoral popliteal bypass graft using a reverse saphe-
nous vein graft. Staining of intraoperative tissue demonstrated
an extremely high burden of fungal elements (Fig. 4), indicating
that the pythium infection remained uncontrolled. The patient
later developed a polymicrobial superinfection of his wounds, and
his vascular repair continued to break down leading to increased
ischemic pain. After several multidisciplinary discussions with the
family that all medical interventions were exhausted, and that
even highly aggressive surgical measures including hip disartic-
ulation or hemipelvectomy could not guarantee source control,
conservative measures were initiated and ultimately, the patient
expired.
3. DiscussionThis patient presented a major diagnostic challenge, and his
disease process and subsequent management were previously
unknown to our hospital. In retrospect, he presented with a classic
rysm (A) axial and (B) coronal section.
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Fig. 4. (A) Hematoxylin and eosin staining of pseudoaneurysm wall shown at 10× demonstrating extensive vessel wall necrosis and (B) Grocott’s methenamine silver stain
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Ethical approvalf  pseudoaneurysm showing clusters of Pythium.
ase of vascular pythiosis, with an antecedent history of exposure to
urface water and exam ﬁndings of vascular insufﬁciency, includ-
ng pain out of proportion to exam, distal emboli, and an ischemic
lcer. The correct infectious diagnosis was not made until 1 month
fter exposure, after a vascular bypass was already performed.
ndeed, in a large multi-institutional study from Thailand with a
otal of 102 cases of pythiosis,7 60 patients received a diagnosis
f vascular pythiosis, and only the patients who had undergone
mputation survived. Further review of the literature for reports of
ascular pythiosis demonstrated that the majority of patients were
reated with amputation without any signs of recurrence, and were
ollowed for 5 to 35 months post-operatively.4,6,8,9 In our case, com-
lete source control was not achieved during the ﬁrst operation
ince the common femoral artery and the proximal portion of the
uperﬁcial femoral artery were oversewn and left in place, standard
ractice for the treatment of peripheral arterial disease. Incomplete
ource control eventually led to development of a pseudoaneurysm
t the proximal anastomosis and additional surgery. While the sec-
nd repair was cited in previously uninvolved tissue planes, it did
ot protect against further infection, likely because P. insidiosum is
nown to invade through proteinase secretion.10 The authors could
nd no reported cases of conﬁrmed vascular pythiosis treated with
imb-sparing procedures.2,7,11,12
Medical therapy in the treatment of vascular pythiosis involves
ntifungal agents, immunotherapy, and iron chelation therapy.13
uch of the difﬁculty in eradicating this organism stems from its
omplicated phylogenesis;2,6,14 it shares features with true fungi at
he same time it is phylogenetically more closely related to algae
nd diatomeae.14 P. insidiosum develops mycelium like fungi, but
ts cell walls do not contain chitin and its cytoplasmic membrane
acks ergosterol,2 both of which are important targets of traditional
ntifungal drugs. Despite this, drugs that affect cellular permeabil-
ty, including amphotericin B, terbinaﬁne, and the azoles, have been
sed with some clinical success.2,15
More recently, immunotherapy has been used as an adjunct to
urgery and antimycotics. Immunotherapy was ﬁrst successfully
sed in humans in 1998 in a patient with a vascular P. insidiosum
nfection refractory to surgery and antifungals.2,16 A P. insidiosum
accine delivered twice with a two-week interval resulted in a cure
 year later. Data collected from clinical trials and other reports
stimate vaccine efﬁcacy to be 55–60%.2,17 The proposed mecha-
ism of action of the P. insidiosum vaccine is to shift host adaptive
mmune response from a predominantly T helper 2 (Th2) response
o a T helper 1 (Th1) response.2,17 Pythium exoantigens are typi-
ally processed by antigen presenting cells (APCs) and presented to
aïve CD4+ helper T cells (Th0). This induces Th0 cells to adopt a Th2
henotype secreting IL-4 and IL-5, which trigger many downstreameffects, including mast cell and eosinophil migration to the site of
infection with subsequent degranulation, releasing inﬂammatory
mediators and causing tissue damage. Loss of tissue architecture
then creates a more favorable environment for these pathogenic
hyphae to take hold. Conversion of a Th2 to Th1 response would
favor secretion of IFN- and IL-2, leading to increased cytotoxic T
lymphocyte recruitment and therefore, direct killing of P. insidio-
sum. In this case, the purpose of injecting IFN- subcutaneously
was to augment a Th1 response, and co-administration of GM-
CSF was to increase the efﬁciency of exoantigen presentation
to APCs.
Another treatment modality used to control this infection is iron
chelation therapy. Given the association between pythium infec-
tion in patients with hemoglobinopathies with a long-standing
history of blood transfusions4,7 and the discovery of a fer-
rochelatase gene in P. insidiosum,18 other research efforts have
focused on elucidating the role of iron overload in P. insidiosum
pathogenesis.13 There is evidence that iron overload from transfu-
sions contributes to derangements in host immunity by impairing
lymphocyte function and altering phagocytosis, leading to a more
susceptible state for infection6,19 and is in fact, a key virulence fac-
tor for the survival of P. insidiosum in the host.13 Correcting iron
overload has been cited as a treatment in infections common in
thalassemia,20 and has also been used in pythiosis. In our patient,
iron chelation with deferasirox seemed to achieve some symptom
relief.
4. Conclusion
In conclusion, this patient’s vascular P. insidiosum infection was
refractory to optimized medical treatment, immunotherapy with
cytokine injections, and surgery. Attempted source control with
limb salvage necessitating vascular bypass was unsuccessful in
treating this case of vascular pythiosis.
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Key learning points
• Clinicians should maintain a high level of suspicion for vascular pythiosis when presented with a patient with an
underlying hemoglobinopathy, exposure to ﬂat water, and exam ﬁndings of vascular insufﬁciency.
• The most important part in managing vascular pythiosis limb infection is adequate source control with amputation.
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